Overview

Hypophosphatemic Rickets in Norway

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.
Details
Lead Sponsor:
Haukeland University Hospital
Treatments:
Alfacalcidol
Hydroxycholecalciferols
Sevelamer